Molecular markers associated with outcome and metastasis in human pancreatic cancer.
about
Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinomaBioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkersAberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.Transcriptional dissection of pancreatic tumors engrafted in mice.EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cellsEvidence for the importance of personalized molecular profiling in pancreatic cancer.Gene silencing of porcine MUC13 and ITGB5: candidate genes towards Escherichia coli F4ac adhesion.CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture.Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal AdenocarcinomaIdentification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axisPrognostic value of PDL1 expression in pancreatic cancerGli promotes epithelial-mesenchymal transition in human lung adenocarcinomasOverexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotypeElevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges.Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma.Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
P2860
Q28291175-294B2DDC-595D-4C90-84B6-25BD283BCA25Q28834154-E016BF7C-D0B5-4D33-954E-7B6AABC50A29Q33643873-18852E7C-F310-4CFE-B156-A6AA5365D947Q33646227-977DCE47-9D36-453C-87CD-55317E1F59FCQ33772571-7A949E56-6170-4840-96DE-B6F49E92E345Q33778507-A9C2BAD0-3FAC-445C-871F-F34F518A09CFQ34387784-617C38CC-CACA-4A91-A813-0FD05B3539B8Q34906764-8BE1C6D2-7DF1-4B1B-8B7A-AB626D008BA3Q35017547-EFDAAF61-5C76-4D92-A35B-A1687F8179F5Q35294099-B1A4EEAD-0D3E-4D4F-A8E2-8B0194E7B7F8Q36107581-40736CB5-9800-4497-A1CD-B28AC8E6E85FQ36367896-AAB057DE-92B0-4444-80C8-F432C81814F3Q37457758-3E61BB51-A7CB-446D-A6C4-D7ACD1520EFAQ37687595-E31A5951-7F8B-415A-B62B-E32D8171B50FQ37697016-26CF4B77-BCDC-498B-A6D9-A971C09C3E72Q38913118-3077F186-18A5-45AE-806B-84E0A64C8F3AQ48225102-55DF5D41-552D-4733-8D92-0FEE85775EAFQ49251004-D7A0D039-FEDD-4241-920B-0FCBB07FA9A8Q51040212-03DD08CA-0CD1-4FDB-B64F-66C0281184A5Q52715864-BE43AC69-A75A-4E22-8EB3-DB50EE4E5457Q54982470-E8C4D4CA-F331-4585-AAEF-F458A1CF4D79Q59127439-BB4B03A5-E554-4957-ADE4-445CA7FD6125
P2860
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@ast
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@en
type
label
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@ast
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@en
prefLabel
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@ast
Molecular markers associated with outcome and metastasis in human pancreatic cancer.
@en
P2093
P2860
P356
P1476
Molecular markers associated with outcome and metastasis in human pancreatic cancer
@en
P2093
Anke Van den Broeck
Baki Topal
Hugo Vankelecom
Rudy Van Eijsden
P2860
P2888
P356
10.1186/1756-9966-31-68
P577
2012-08-27T00:00:00Z
P5875
P6179
1036973123